-
Loading metrics
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature
- Mark P. Labrecque,
- Lisha G. Brown,
- Ilsa M. Coleman,
- Holly M. Nguyen,
- Daniel W. Lin,
- Eva Corey,
- Peter S. Nelson,
- Colm Morrissey
x
- Published: January 20, 2021
- https://doi.org/10.1371/journal.pone.0245602